rethinkPeptides Search
Menu
Study breakdown

MOTS-c: The Mitochondrial Peptide That Links Exercise, Metabolism, and Aging

ReviewExpert Review evidence
The takeaway

MOTS-c is a peptide made by your mitochondria that activates during exercise and stress, turning on protective genes through the AMPK energy-sensing pathway — and it may be key to healthy aging.

Mitochondria → Nucleus signaling

MOTS-c is one of the first discovered peptides that carries signals from mitochondria back to the cell nucleus, challenging the view of mitochondria as passive energy producers

What the researchers found

MOTS-c is a peptide encoded by mitochondrial DNA (specifically within the 12S rRNA gene) that acts as a signaling molecule between mitochondria and the cell nucleus. When activated by stress or exercise, MOTS-c moves to the nucleus and turns on genes with antioxidant response elements (ARE) that help cells adapt to stress.

Its primary mechanism involves the Folate-AICAR-AMPK pathway — the same master energy-sensing pathway activated by exercise and the diabetes drug metformin. Through this pathway, MOTS-c influences energy metabolism, insulin sensitivity, inflammation, exercise response, and multiple age-related diseases. The review positions MOTS-c as a key molecule for maintaining the balance between energy production and stress resistance that deteriorates during aging.

Why it matters

MOTS-c is part of a newly discovered class of mitochondrial-derived peptides that challenge the old view of mitochondria as simple energy factories. The fact that mitochondria produce signaling peptides that travel to the nucleus and regulate gene expression represents a fundamental shift in cell biology. For aging research specifically, MOTS-c is exciting because it connects exercise, metabolism, and stress resistance through a single molecular pathway — potentially explaining why exercise is so protective against age-related disease and opening new therapeutic possibilities.

The numbers in context

Encoded by mitochondrial 12S rRNA gene · Acts via Folate-AICAR-AMPK pathway · Regulates antioxidant response element (ARE) genes · Influences insulin resistance, inflammation, metabolism, aging

How the study worked

Comprehensive review article synthesizing published research on MOTS-c's molecular mechanisms, including its retrograde signaling to the nucleus, AMPK pathway activation, metabolic effects, stress homeostasis roles, and connections to aging-related diseases.

Who was studied

Not applicable (review article)

What this study cannot tell us

As a review, this synthesizes existing research rather than presenting new data. Much of the MOTS-c research is preclinical (cell culture and animal studies). Human clinical data is limited. The precise mechanisms by which MOTS-c levels decline with age and how this contributes to disease are still being worked out. Therapeutic applications remain theoretical.

How to read the evidence

This is a comprehensive expert review published in a peer-reviewed translational medicine journal. It synthesizes a growing body of preclinical research, but human clinical evidence for MOTS-c therapeutic applications remains limited.

When this study was published

Published in 2023. This is a current review capturing the state of MOTS-c research through 2022, a rapidly evolving field in mitochondrial biology and aging science.

The bigger picture

MOTS-c belongs to a new class of mitochondrial-derived peptides (MDPs) discovered in the last decade. These peptides have rewritten the textbook on mitochondrial biology — showing that mitochondria don't just make energy but actively communicate with the rest of the cell to coordinate stress responses. MOTS-c in particular has become central to the 'exercise mimetic' concept: the idea that a molecule could replicate some of exercise's protective effects. While still mostly preclinical, MOTS-c research is informing new approaches to metabolic disease, neurodegeneration, and healthy aging.

Questions still open

  • Can administering MOTS-c replicate the metabolic benefits of exercise in people who are unable to exercise?
  • Why do MOTS-c levels decline with age, and can this decline be prevented or reversed?
  • Could MOTS-c be developed into a therapeutic for insulin resistance or age-related metabolic disease?

Common questions

What does MOTS-c actually do in your body?
MOTS-c is a signaling peptide made by your mitochondria. When you exercise or your cells are stressed, MOTS-c moves to the nucleus and activates genes that help your body handle stress, manage energy, and reduce inflammation. It works through the AMPK pathway — the same energy sensor targeted by the diabetes drug metformin — improving insulin sensitivity and metabolic function.
Can you take MOTS-c as a supplement?
MOTS-c is not currently available as an approved supplement or drug. Research on administering MOTS-c is mostly in animal models. However, exercise naturally increases MOTS-c production, which may be one reason exercise is so beneficial for metabolic health and aging.

Read the original research

Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging.

Journal of translational medicine, 21(1), 36

Citation

Wan, Wei; Zhang, Lieliang; Lin, Yue; Rao, Xiuqing; Wang, Xifeng; Hua, Fuzhou; Ying, Jun. (2023). Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging.. Journal of translational medicine, 21(1), 36. https://doi.org/10.1186/s12967-023-03885-2